Holen Sie sich die Stockscreener-App
33.09
1.58%
-0.53
Handel nachbörslich:
33.25
0.16
+0.48%
Schlusskurs vom Vortag:
$33.62
Offen:
$33.48
24-Stunden-Volumen:
513.50K
Relative Volume:
0.96
Marktkapitalisierung:
$1.52B
Einnahmen:
$1.15B
Nettoeinkommen (Verlust:
$23.09M
KGV:
66.18
EPS:
0.5
Netto-Cashflow:
$89.18M
1W Leistung:
+4.68%
1M Leistung:
+17.05%
6M Leistung:
-16.19%
1J Leistung:
-26.14%
1-Tages-Spanne:
$32.91
$33.75
1-Wochen-Bereich:
$31.34
$33.75
52-Wochen-Spanne:
$22.66
$55.74
Omnicell Inc Stock (OMCL) Company Profile
Firmenname
Omnicell Inc
Sektor
Branche
Telefon
(877) 415-9990
Adresse
4220 NORTH FREEWAY, FORT WORTH
Vergleichen Sie OMCL mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
33.09 | 1.45B | 1.15B | 23.09M | 89.18M | 0.50 |
|
VEEV
Veeva Systems Inc
|
285.25 | 46.10B | 2.86B | 780.66M | 1.19B | 4.72 |
|
TEM
Tempus Ai Inc
|
75.90 | 13.63B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
66.38 | 12.35B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
87.42 | 7.74B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
35.90 | 6.32B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-05-14 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-02 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Eingeleitet | Barclays | Underweight |
| 2023-11-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-11-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Bestätigt | Wells Fargo | Underweight |
| 2023-08-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Eingeleitet | BofA Securities | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-12-06 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-06-09 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-24 | Eingeleitet | BTIG Research | Buy |
| 2021-02-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-12-03 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-02-07 | Bestätigt | Dougherty & Company | Buy |
| 2019-11-21 | Bestätigt | Dougherty & Company | Buy |
| 2019-07-26 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-03-07 | Bestätigt | Dougherty & Company | Buy |
| 2018-06-29 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-09-05 | Bestätigt | The Benchmark Company | Buy |
| 2017-07-28 | Bestätigt | Dougherty & Company | Buy |
| 2017-04-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Eingeleitet | Dougherty & Company | Buy |
| 2016-12-06 | Bestätigt | The Benchmark Company | Buy |
| 2016-07-07 | Bestätigt | FBR Capital | Outperform |
| 2016-03-21 | Bestätigt | Topeka Capital Markets | Buy |
| 2016-01-07 | Eingeleitet | The Benchmark Company | Buy |
| 2015-11-16 | Bestätigt | Topeka Capital Markets | Buy |
| 2015-10-30 | Bestätigt | FBR Capital | Outperform |
| 2015-09-28 | Hochstufung | Sidoti | Neutral → Buy |
| 2015-07-31 | Bestätigt | Topeka Capital Markets | Buy |
Alle ansehen
Omnicell Inc Aktie (OMCL) Neueste Nachrichten
How to integrate Omnicell Inc. into portfolio analysis tools2025 Top Gainers & Real-Time Market Trend Scan - Newser
How to use Fibonacci retracement on Omnicell Inc.2025 Year in Review & Weekly Top Gainers Alerts - Newser
Key metrics from Omnicell Inc.’s quarterly dataTrade Exit Summary & Technical Pattern Based Buy Signals - Newser
Is Omnicell Inc. a candidate for recovery playWeekly Profit Analysis & Consistent Return Investment Signals - Newser
Sector ETF performance correlation with Omnicell Inc.Weekly Loss Report & Verified Momentum Watchlists - Newser
KeyBanc reiterates Sector Weight rating on Omnicell stock - Investing.com
Real time pattern detection on Omnicell Inc. stockQuarterly Trade Summary & Intraday High Probability Alerts - Newser
Has Omnicell Inc. formed a bullish divergenceJuly 2025 Short Interest & Safe Capital Growth Trade Ideas - Newser
What moving averages say about Omnicell Inc.Stop Loss & Technical Pattern Based Signals - Newser
Technical signs of recovery in Omnicell Inc.July 2025 Breakouts & Free Verified High Yield Trade Plans - Newser
Sentiment analysis tools applied to Omnicell Inc.July 2025 Price Swings & AI Powered Market Trend Analysis - Newser
Is Omnicell Inc. showing signs of accumulationJuly 2025 Institutional & Intraday High Probability Alerts - Newser
Can trapped investors hope for a rebound in Omnicell Inc.Trade Exit Summary & Weekly High Potential Stock Alerts - Newser
Evaluating Omnicell Inc. with trendline analysisEarnings Risk Summary & Technical Buy Zone Confirmation - Newser
Visual analytics tools that track Omnicell Inc. performanceJuly 2025 Update & Safe Entry Zone Identification - Newser
Is This the Dip to Buy in Omnicell Inc.Market Movement Recap & Low Risk Entry Point Tips - classian.co.kr
What earnings revisions data tells us about Omnicell Inc.Insider Selling & Verified Swing Trading Watchlist - Newser
Is it too late to sell Omnicell Inc.July 2025 Snapshot & Free Low Drawdown Momentum Trade Ideas - Newser
Using R and stats models for Omnicell Inc. forecasting2025 Support & Resistance & Intraday High Probability Setup Alerts - Newser
What makes Omnicell Inc. stock price move sharply2025 Support & Resistance & Consistent Profit Alerts - Newser
Inside Omnicell’s Austin Lab: Building the Pharmacy of the Future with AI and Robotics - KEYE
Omnicell Inc. Bounces Off Moving Average SupportEarnings Performance Report & Smart Allocation Stock Tips - beatles.ru
Omnicell Inc. recovery potential after sell offQuarterly Growth Report & Community Driven Trade Alerts - Newser
Pharmacy Automation Company Evaluation Report 2025 | BD, Omnicell, and Capsa Healthcare Lead in Medical Technology, Pharmacy Automation, and Medication Management Solutions - Yahoo Finance
How to escape a deep drawdown in Omnicell Inc.Quarterly Portfolio Report & Weekly Setup with ROI Potential - Newser
Is Omnicell Inc. stock bottoming outEarnings Growth Summary & Stock Portfolio Risk Control - Newser
Omnicell outlines $40M tariff impact and anticipates $1.105B-$1.155B revenue for 2025 - MSN
Trapped Investors in Omnicell Inc. Await Breakout SignalBull Run & Safe Entry Momentum Stock Tips - beatles.ru
OMCL Q2 Deep Dive: Product Innovation and Recurring Revenue Drive Upbeat Guidance - Yahoo Finance
5 Must-Read Analyst Questions From Omnicell’s Q2 Earnings Call - Yahoo Finance
Did Strong Q2 Results and Improved Profitability Just Shift Omnicell’s (OMCL) Investment Narrative? - simplywall.st
Omnicell (NASDAQ:OMCL) Given a $55.00 Price Target by Piper Sandler Analysts - Defense World
Omnicell (NASDAQ:OMCL) PT Set at $55.00 by Piper Sandler - Defense World
Bruker, Viatris, Sotera Health Company, Align Technology, and Omnicell Stocks Trade Up, What You Need To Know - Yahoo Finance
Piper Sandler Maintains Omnicell(OMCL.US) With Buy Rating, Cuts Target Price to $55 - 富途牛牛
Omnicell price target lowered to $55 from $57 at Piper Sandler - TipRanks
Piper Sandler lowers Omnicell stock price target to $55 on tariff concerns - Investing.com Nigeria
Omnicell, Inc. (NASDAQ:OMCL) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Omnicell (NASDAQ:OMCL) Downgraded to “Buy” Rating by Wall Street Zen - Defense World
Best data tools to analyze Omnicell Inc. stockFree Trade Ready Stock Watch for Short Term - Newser
Does Omnicell Inc. show high probability of reboundPredictive System for Long-Term Stock Forecast - Newser
Intraday pattern recognizer results for Omnicell Inc.Portfolio Booster Strategy with Trend Confidence - Newser
Why Omnicell Inc. stock attracts strong analyst attentionEntry and Exit Strategy for Swing Traders - Newser
Can Omnicell Inc. rally from current levelsTriple Digit Gain Opportunity Watchlist - Newser
Central Fill Pharmacy Automation Market is evolving rapidly ThroNORTHEAST - NORTHEAST - NEWS CHANNEL NEBRASKA
Price action breakdown for Omnicell Inc.AI Triggered Buy Zone Forecast System - Newser
How Investors Are Reacting To Omnicell (OMCL) Q2 Revenue Growth and Raised Full-Year Guidance - simplywall.st
Omnicell 2025 Q2 Earnings Strong Performance as Net Income Surges 51% - AInvest
Omnicell’s Earnings Call Highlights Strong Growth and Strategic Wins - The Globe and Mail
Finanzdaten der Omnicell Inc-Aktie (OMCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Omnicell Inc-Aktie (OMCL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| PARRISH MARK W | Director |
Dec 10 '24 |
Sale |
47.30 |
12,000 |
567,638 |
58,427 |
2.23%
2.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):